SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001535384-23-000001
Filing Date
2023-01-27
Accepted
2023-01-27 12:49:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 KTA NBSE 13G AMEND nbse13g-amend2.htm SC 13G/A 26063
2 KTA NBSE 13G AMEND ktanbse13gamend.pdf SC 13G/A 708120
  Complete submission text file 0001535384-23-000001.txt   1002325
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Subject) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-82720 | Film No.: 23561134
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1825B KRAMER LANE SUITE 200 AUSTIN TX 78758
Business Address 1825B KRAMER LANE SUITE 200 AUSTIN TX 78758 512-439-8140
Kershner Trading Americas,LLC (Filed by) CIK: 0001535384 (see all company filings)

IRS No.: 262018299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A